Archford Capital Strategies’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $376K | Sell |
1,038
-16
| -2% | -$5.48K | 0.04% | 280 |
|
|
2026
Q1 | $371K | Sell |
1,054
-311
| -23% | -$111K | 0.04% | 260 |
|
|
2025
Q4 | $447K | Hold |
1,365
| – | – | 0.05% | 241 |
|
|
2025
Q3 | $385K | Sell |
1,365
-831
| -38% | -$241K | 0.05% | 249 |
|
|
2025
Q2 | $613K | Sell |
2,196
-619
| -22% | -$175K | 0.08% | 200 |
|
|
2025
Q1 | $877K | Sell |
2,815
-3,019
| -52% | -$891K | 0.13% | 158 |
|
|
2024
Q4 | $1.52M | Buy |
5,834
+71
| +1% | +$21.1K | 0.23% | 105 |
|
|
2024
Q3 | $1.87M | Sell |
5,763
-529
| -8% | -$173K | 0.28% | 89 |
|
|
2024
Q2 | $1.97M | Buy |
6,292
+66
| +1% | +$19.4K | 0.32% | 78 |
|
|
2024
Q1 | $1.77M | Buy |
6,226
+334
| +6% | +$97.7K | 0.3% | 89 |
|
|
2023
Q4 | $1.7M | Buy |
5,892
+606
| +11% | +$165K | 0.31% | 88 |
|
|
2023
Q3 | $1.42M | Sell |
5,286
-308
| -6% | -$76.9K | 0.28% | 90 |
|
|
2023
Q2 | $1.32M | Buy |
5,594
+140
| +3% | +$32.5K | 0.25% | 94 |
|
|
2023
Q1 | $1.38M | Buy |
5,454
+371
| +7% | +$91.1K | 0.29% | 83 |
|
|
2022
Q4 | $1.34M | Buy |
5,083
+736
| +17% | +$197K | 0.31% | 81 |
|
|
2022
Q3 | $980K | Buy |
4,347
+387
| +10% | +$93.8K | 0.25% | 101 |
|
|
2022
Q2 | $963K | Buy |
3,960
+299
| +8% | +$73.3K | 0.24% | 100 |
|
|
2022
Q1 | $895K | Buy |
3,661
+271
| +8% | +$62.3K | 0.2% | 125 |
|
|
2021
Q4 | $763K | Buy |
3,390
+132
| +4% | +$27.9K | 0.17% | 142 |
|
|
2021
Q3 | $693K | Buy |
3,258
+156
| +5% | +$35.9K | 0.16% | 149 |
|
|
2021
Q2 | $756K | Buy |
3,102
+54
| +2% | +$13.3K | 0.19% | 139 |
|
|
2021
Q1 | $778K | Sell |
3,048
-9,319
| -75% | -$2.22M | 0.21% | 130 |
|
|
2020
Q4 | $2.95M | Buy |
12,367
+73
| +0.6% | +$16.8K | 0.68% | 34 |
|
|
2020
Q3 | $3.13M | Sell |
12,294
-10
| -0.1% | -$2.48K | 0.84% | 26 |
|
|
2020
Q2 | $2.9M | Buy |
12,304
+198
| +2% | +$45.2K | 0.86% | 22 |
|
|
2020
Q1 | $2.45M | Sell |
12,106
-209
| -2% | -$45.7K | 0.96% | 23 |
|
|
2019
Q4 | $2.97M | Sell |
12,315
-715
| -5% | -$158K | 1.02% | 19 |
|
|
2019
Q3 | $2.52M | Sell |
13,030
-30
| -0.2% | -$5.76K | 0.94% | 22 |
|
|
2019
Q2 | $2.41M | Buy |
13,060
+289
| +2% | +$51.7K | 0.88% | 23 |
|
|
2019
Q1 | $2.43M | Sell |
12,771
-121
| -0.9% | -$23.1K | 0.89% | 24 |
|
|
2018
Q4 | $2.51M | Buy |
12,892
+308
| +2% | +$60.1K | 1.01% | 22 |
|
|
2018
Q3 | $2.61M | Sell |
12,584
-703
| -5% | -$139K | 0.95% | 19 |
|
|
2018
Q2 | $2.45M | Buy |
13,287
+1,049
| +9% | +$186K | 0.86% | 20 |
|
|
2018
Q1 | $2.13M | Buy |
12,238
+19
| +0.2% | +$3.49K | 0.89% | 38 |
|
|
2017
Q4 | $2.13M | Buy |
12,219
+528
| +5% | +$93.4K | 0.79% | 39 |
|
|
2017
Q3 | $2.18M | Buy |
11,691
+2,567
| +28% | +$455K | 0.82% | 37 |
|
|
2017
Q2 | $1.57M | Buy |
9,124
+1,056
| +13% | +$172K | 0.62% | 50 |
|
|
2017
Q1 | $1.33M | Buy |
+8,068
| New | +$1.34M | 0.5% | 60 |
|
|
2016
Q4 | – | Sell |
-3,957
| Closed | -$660K | – | 628 |
|
|
2016
Q3 | $660K | Buy |
3,957
+3,938
| +20,726% | +$666K | 0.27% | 124 |
|
|
2016
Q2 | $3K | Buy |
+19
| New | +$2.95K | ﹤0.01% | 562 |
|
|
2016
Q1 | – | Sell |
-19
| Closed | -$4K | – | 192 |
|
|
2015
Q4 | $4K | Hold |
19
| – | – | ﹤0.01% | 585 |
|
|
2015
Q3 | $3K | Hold |
19
| – | – | ﹤0.01% | 526 |
|
|
2015
Q2 | $3K | Hold |
19
| – | – | ﹤0.01% | 415 |
|
|
2015
Q1 | $3.04K | Hold |
19
| – | – | ﹤0.01% | 446 |
|
|
2014
Q4 | $3K | Hold |
19
| – | – | ﹤0.01% | 425 |
|
|
2014
Q3 | $3K | Hold |
19
| – | – | ﹤0.01% | 429 |
|
|
2014
Q2 | $2.25K | Hold |
19
| – | – | ﹤0.01% | 663 |
|
|
2014
Q1 | $2.34K | Buy |
+19
| New | +$2.3K | ﹤0.01% | 632 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Archford Capital Strategies's AMGN Position: Q2 2026 in Review
Archford Capital Strategies reduced its Amgen (AMGN) stake by 1.5% in Q2 2026, selling an estimated $5.48K and leaving 1,038 shares worth $376K. The position accounts for 0.04% of the portfolio, ranked #280.
Archford Capital Strategies first reported a position in AMGN in Q1 2014 and has held it in 48 quarters since. The position peaked at $3.13M in Q3 2020. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Archford Capital Strategies held 1,038 shares of Amgen worth $376K as of Q2 2026.
- Archford Capital Strategies sold 16 Amgen shares in Q2 2026, an estimated $5.48K.
- Amgen made up 0.04% of Archford Capital Strategies's portfolio in Q2 2026, its #280 holding.
- Archford Capital Strategies first reported a position in Amgen in Q1 2014 and has held it in 48 quarters since.
- Archford Capital Strategies's Amgen position peaked at $3.13M in Q3 2020.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.